Find public sector tenders

The contract is for the provision of a clinical and cost-effectiveness model for Human Papillomavirus (HPV) Screening in vaccinated populations.

Provision of services to develop a cost-effective model to determine whether cervical cancer screening is clinically and cost effective in vaccinated populations in the UK.

Provision of services to develop a cost-effective model to determine whether cervical cancer screening is clinically and cost effective in vaccinated populations in the UK. This model will project and compare the health benefits, harms, and costs ass ....

The provision of human papillomavirus vaccine, deliveries will be required from 1 April 2021 to 31 March 2025 Value - this information is considered by the supplier to be commercially sensitive information. The authority is not publishing the value s ....

The provision of human papillomavirus vaccine.

The provision of human papillomavirus vaccine, deliveries will berequired from 1 April 2021 to 31 March 2025

NHS Supply Chain seeks to establish a comprehensive, non-exclusive, framework agreement for the supply to the NHS supply chain customer base via the E-Direct/Direct Route of Liquid-Based Cytology Systems and High-Risk Human Papillomavirus Testing Sys ....

The supply of human papillomavirus vaccine, deliveries will be required over a period of 1 year.

CPV Codes - 33124110, 33124130, 50412000, 51410000, 33124100, 33141625, 33124130, 38434000, 33696500 OJEU Ref - 2015/S 019-030175

Liquid Based Cytology Systems for Cervical Screening and High Risk HPV (Human Papillomavirus) Testing Systems.